ArticleCurrent medical imaging2025
Federated Deep Learning Approaches for Detecting Ocular Diseases in Medical Imaging: A Systematic Review.
Article in Current medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Federated learning for privacy-preserving ophthalmic artificial intelligence: clinical applications and translational challenges.Frontiers in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionArtificial intelligence has significantly enhanced disease diagnosis in healthcare, particularly through Deep Learning (DL) and Federated Learning (FL) approaches. These technologies have shown promise in detecting ocular diseases using medical imaging while addressing challenges related to data privacy and security. FL enables collaborative learning without sharing sensitive medical data, making it an attractive solution for healthcare applications. This systematic review aims to analyze the advancements in AI-driven ocular disease detection, with a particular focus on FL-based approaches. The article evaluates the evolution, methodologies, challenges, and effectiveness of FL in enhancing diagnostic accuracy while ensuring data confidentiality.
methodsThe systematic review followed the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) framework to ensure transparency and reliability. Research articles published between 2017 and 2024 were identified using academic databases, including Web of Science, Scopus, IEEE Xplore, and PubMed. Studies focusing on DL and FL models for detecting ocular diseases were selected based on predefined inclusion and exclusion criteria. A comparative analysis of the methodologies, architectures, datasets, and performance metrics of different FL models has been presented. RESULTS AND DISCUSSION: The findings indicated that FL preserves data privacy while achieving diagnostic performance comparable to traditional centralized AI models. Various FL models, including FedAvg and FedProx, have been implemented for ocular disease detection, with high accuracy and efficiency. However, challenges, such as data heterogeneity, communication efficiency, and model convergence, persist.
conclusionFL represents a promising approach for ocular disease detection, balancing diagnostic accuracy with data privacy. Future research may focus on optimizing FL frameworks for improving scalability, communication efficiency, and integrating advanced privacy-preserving techniques.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.